Leslie Montejano

1.3k total citations
30 papers, 1.0k citations indexed

About

Leslie Montejano is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Psychiatry and Mental health. According to data from OpenAlex, Leslie Montejano has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Public Health, Environmental and Occupational Health and 8 papers in Psychiatry and Mental health. Recurrent topics in Leslie Montejano's work include Substance Abuse Treatment and Outcomes (8 papers), Opioid Use Disorder Treatment (8 papers) and Attention Deficit Hyperactivity Disorder (4 papers). Leslie Montejano is often cited by papers focused on Substance Abuse Treatment and Outcomes (8 papers), Opioid Use Disorder Treatment (8 papers) and Attention Deficit Hyperactivity Disorder (4 papers). Leslie Montejano collaborates with scholars based in United States, France and Ireland. Leslie Montejano's co-authors include Richard H. Dougherty, Allen S. Daniels, D. Russell Lyman, Sushmita Shoma Ghose, Meelee Kim, Miriam E. Delphin-Rittmon, Catherine A. Fullerton, Cindy Parks Thomas, Paul Hodgkins and Rahul Sasané and has published in prestigious journals such as The Journal of Urology, Addiction and Schizophrenia Research.

In The Last Decade

Leslie Montejano

30 papers receiving 987 citations

Peers

Countries citing papers authored by Leslie Montejano

Since Specialization

Citations

This map shows the geographic impact of Leslie Montejano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Montejano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Montejano more than expected).

Fields of papers citing papers by Leslie Montejano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Montejano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Montejano. The network helps show where Leslie Montejano may publish in the future.

Co-authorship network of co-authors of Leslie Montejano

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Montejano. A scholar is included among the top collaborators of Leslie Montejano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Montejano. Leslie Montejano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The relationship between Eastern Cooperative Oncology Group performance status and healthcare resource utilization among patients with advanced or metastatic colorectal, lung or gastric cancer 2020 ·PubMed ·Lisa M. Hess, David M. Smith, Zhanglin Lin Cui, Leslie Montejano, Astra M. Liepa, William R. Schelman, Lee Bowman	7
2	Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder 2018 ·PubMed ·Naoko Ronquest, Tina M. Willson, Leslie Montejano, Vijay R. Nadipelli, Bernd Wollschlaeger	74
3	Treatment Patterns in Patients with Type 2 Diabetes Mellitus Treated with GLP-1 Receptor Agonists: Higher Adherence and Persistence with Dulaglutide Compared to Exenatide QW and Liraglutide 2017 ·Diabetes Obesity and Metabolism ·Carlos Alatorre, Laura Fernández Landó, Miao Yu, (unknown), Leslie Montejano, Paul Juneau, Reema Mody, Ralph Swindle	3
4	Characteristics and treatment patterns of US commercially insured and Medicaid patients with opioid dependence or abuse 2017 ·Journal of Opioid Management ·Bernd Wollschlaeger, Tina M. Willson, Leslie Montejano, Naoko Ronquest, Vijay R. Nadipelli	21
5	Transitions of Care for People with Type 2 Diabetes: Utilization of Antihyperglycemic Agents Pre- and Post-Hospitalization 2015 ·Diabetes Therapy ·Leslie Montejano, Lien Vo, Donna McMorrow	14
6	Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics 2015 ·Drugs - Real World Outcomes ·Jacqueline Pesa, Erik Muser, Leslie Montejano, David M. Smith, Oren Meyers	27
7	Real‐World Dosing Patterns of Atomoxetine in Adults with Attention‐Deficit/Hyperactivity Disorder 2015 ·CNS Neuroscience & Therapeutics ·(unknown), Carlos Alatorre, Leslie Montejano, Amanda M. Farr, David B. Clemow	8
8	Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence 2015 ·FOCUS The Journal of Lifelong Learning in Psychiatry ·(unknown), Catherine A. Fullerton, Meelee Kim, Leslie Montejano, D. Russell Lyman, Richard H. Dougherty, Allen S. Daniels, Sushmita Shoma Ghose, Miriam E. Delphin-Rittmon	13
9	Assessing The Incidence And Treatment Of Post-Treatment Lyme Disease Syndrome In An Administrative Claims Database 2014 ·Value in Health ·Leslie Montejano	2
10	Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence 2013 ·Psychiatric Services ·Cindy Parks Thomas, Catherine A. Fullerton, Meelee Kim, Leslie Montejano, D. Russell Lyman, Richard H. Dougherty, Allen S. Daniels, Sushmita Shoma Ghose, Miriam E. Delphin-Rittmon	168
11	Healthcare Costs Associated with Osteoarthritis in US Patients 2012 ·Pain Practice ·T. Kim Le, Leslie Montejano, Zhun Cao, Yang Zhao, Dennis C. Ang	34
12	Risk of Injury Associated With Attention-Deficit/Hyperactivity Disorder in Adults Enrolled in Employer-Sponsored Health Plans 2011 ·The Primary Care Companion For CNS Disorders ·Paul Hodgkins, Leslie Montejano, Rahul Sasané, (unknown)	16
13	Adult ADHD: prevalence of diagnosis in a US population with employer health insurance 2011 ·Current Medical Research and Opinion ·Leslie Montejano, Rahul Sasané, Paul Hodgkins, Leo Russo, Daniel M. Huse	40
14	Cost of Illness and Comorbidities in Adults Diagnosed With Attention-Deficit/Hyperactivity Disorder 2011 ·The Primary Care Companion For CNS Disorders ·Paul Hodgkins, Leslie Montejano, Rahul Sasané, (unknown)	60
15	Comparison of healthcare utilization among patients treated with alcoholism medications. 2010 ·PubMed ·Tami L. Mark, Leslie Montejano, Henry R. Kranzler, Mady Chalk, David R. Gastfriend	23
16	Effects of Naltrexone Treatment for Alcohol‐Related Disorders on Healthcare Costs in an Insured Population 2010 ·Alcoholism Clinical and Experimental Research ·Henry R. Kranzler, Leslie Montejano, Judith J. Stephenson, (unknown), David R. Gastfriend	5
17	Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder 2009 ·Schizophrenia Research ·Leslie Citrome, Christopher Reist, Liisa Palmer, Leslie Montejano, Gregory Lenhart, Brian J. Cuffel, James Harnett, Kafi N. Sanders	16
18	Persistence with oral naltrexone for alcohol treatment: implications for health‐care utilization 2008 ·Addiction ·Henry R. Kranzler, Judith J. Stephenson, Leslie Montejano, (unknown), David R. Gastfriend	48
19	Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder 2008 ·Schizophrenia Research ·Leslie Citrome, Christopher Reist, Liisa Palmer, Leslie Montejano, (unknown), Brian J. Cuffel, James Harnett, Kafi N. Sanders	28
20	Factors affecting detoxification readmission: Analysis of public sector data from three states 2006 ·Journal of Substance Abuse Treatment ·Tami L. Mark, Rita Vandivort-Warren, Leslie Montejano	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact